Kinetics of Insulin Secretion from MIN6 Pseudoislets after Encapsulation in a Prototype Device of a Bioartificial Pancreas

Abstract

Xenotransplantation of insulin-secreting cells from nonhuman sources is an alternative therapeutic approach to bypass the shortage of human pancreatic islet tissue for transplantation in order to treat insulin deficiency in type 1 diabetes mellitus. Therefore, we studied the suitability of pseudoislets generated from insulin-secreting MIN6 tissue culture cells to serve as a surrogate for replacement of pancreatic islets after encapsulation in a minicell, representing a prototype of a new bioartificial pancreas device. MIN6 pseudoislets showed an excellent insulin secretory responsiveness with a typical biphasic secretory pattern to glucose stimulation. When encapsulated in the minicell, insulin release from the pseudoislets in response to glucose stimulation was reduced. The initial first phase insulin secretory response was greatly attenuated. In contrast, the first phase insulin secretory response of the encapsulated pseudoislets was restored on stimulation with the sulfonylurea drug tolbutamide. Our results indicate that the reason for the attenuated first phase of release is the restricted permeability of the pores in the separating membrane in the minicell for the hydrophilic glucose molecule rather than a limited permeability for the secretion product insulin. The reduced release of insulin from the encapsulated pseudoislets could be compensated by overexpression of glucokinase in MIN6 cells, which resulted in an increased glucose responsiveness of the pseudoislets for stimulation with glucose. Thus, this minicell is a well-suited miniature test system for the evaluation of the feasibility of encapsulation of insulin-secreting cells and allows the testing of permeability properties of separating membranes in bioartificial pancreas devices.

MIN6 cells - pseudoislets - minicell - encapsulation - perifusion - glucose-induced insulin secretion

References

• 1 Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation.  Methods Mol Biol. 2006;  333 47-104
• 2 Pavlakis M, Khwaja K. Pancreas and islet cell transplantation in diabetes.  Curr Opin Endocrinol Diabetes Obes. 2007;  14 146-150
• 3 Schweiger M, Steffl M, Amselgruber WM. Clusterin expression in porcine endocrine cells during islet development.  Hormone and metabolic research Hormon- und Stoffwechselforschung. 2007;  39 862-866
• 4 Beck J, Angus R, Madsen B, Britt D, Vernon B, Nguyen KT. Islet encapsulation: strategies to enhance islet cell functions.  Tissue Eng. 2007;  13 589-599
• 5 Baltrusch S, Lenzen S. Novel insights into the regulation of the bound and diffusible glucokinase in MIN6 beta-cells.  Diabetes. 2007;  56 1305-1315
• 6 Jesser C, Kessler L, Lambert A, Belcourt A, Pinget M. Pancreatic islet macroencapsulation: a new device for the evaluation of artificial membrane.  Artif Organs. 1996;  20 997-1007
• 7 Kessler L, Legeay G, Coudreuse A, Bertrand P, Poleunus C, Eynde X van den, Mandes K, Marchetti P, Pinget M, Belcourt A. Surface treatment of polycarbonate films aimed at biomedical application.  J Biomater Sci Polym Ed. 2003;  14 1135-1153
• 8 Kessler L, Legeay G, West R, Belcourt A, Pinget M. Physicochemical and biological studies of corona-treated artificial membranes used for pancreatic islets encapsulation: mechanism of diffusion and interface modification.  J Biomed Mater Res. 1997;  34 235-245
• 9 Olivares E, Piranda S, Malaisse WJ. Long-term correction of hyperglycaemia in streptozotocin-induced diabetic rats transplanted with islets placed in an implantation device.  Horm Metab Res. 2001;  33 687-688
• 10 Panten U, Ishida H, Schauder P, Frerichs H, Hasselblatt A. A versatile microperifusion system.  Anal Biochem. 1977;  82 317-326
• 11 Lenzen S. Insulin secretion by isolated perfused rat and mouse pancreas.  Am J Physiol. 1979;  236 E391-E400
• 12 Hauge-Evans AC, Squires PE, Persaud SJ, Jones PM. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.  Diabetes. 1999;  48 1402-1408
• 13 Luther MJ, Hauge-Evans A, Souza KL, Jörns A, Lenzen S, Persaud SJ, Jones PM. MIN6 beta-cell-beta-cell interactions influence insulin secretory responses to nutrients and non-nutrients.  Biochem Biophys Res Commun. 2006;  343 99-104

Correspondence